INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

(NASDAQ:SANA), NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ: SANA) and certain officers. The class action, filed in the United States District Court for the Western District of Washington, and docketed under 25-cv-00512, is on […]

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN

(NASDAQ:GERN), NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-02563, is on behalf

authID Joins the Secure Technology Alliance to Advance the Development of Global Identity Standards Across Authentication Technologies

(NASDAQ:AUID), This membership underscores commitment to enhancing data protection and user privacy through industry collaboration DENVER, COLORADO, April 17, 2025 (GLOBE NEWSWIRE) — authID(R) (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced its membership in the Secure Technology Alliance (STA), a prominent industry association dedicated to promoting the understanding,

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Quantum Computing Inc. and Certain Officers – QUBT

(NASDAQ:QUBT), NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01457, is on

Nametag Launches Adaptive e-ID Verification(TM), Integration with India’s Aadhaar National Digital Identity System

SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) — Nametag, the identity verification platform known for pioneering Deepfake Defense(TM) and Adaptive Document Verification(TM), today expanded its global leadership with the launch of Adaptive e-ID Verification(TM), a new capability that enables people to verify their identity using their government-issued digital ID (e-ID) in place of a physical identity

Playtika Announces Date of First Quarter 2025 Results Conference Call

(NASDAQ:PLTK), HERZLIYA, Israel, April 17, 2025 (GLOBE NEWSWIRE) — Playtika Holding Corp. (NASDAQ:PLTK) announced today that it will release financial results for the first quarter of 2025 before U.S. markets open on Thursday, May 8, 2025. On the same day, Playtika management will hold a conference call to discuss the results at 5:30 AM Pacific

Tilray Medical Introduces Cannabis Edibles in Australia

(NASDAQ:TLRY),(TSX:TLRY), SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) — Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles,

GSI Technology to Announce Fiscal Fourth Quarter and Year End 2025 Results on May 1, 2025

(NASDAQ:GSIT), SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute (HPC) processing providing true compute-in-memory technology, will announce financial results for its fiscal fourth quarter and year ended March 31, 2025 after the

Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

(NASDAQ:ARQT), WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report first quarter 2025 financial results and provide a business update on Tuesday, May 6, 2025 after the U.S. financial markets close. The Company

Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer

(NASDAQ:DSGN), CARLSBAD, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of Chris M. Storgard, M.D., as Chief Medical Officer (CMO). Dr. Storgard brings over two decades of leadership and hands-on drug development experience, having successfully advanced

Scroll to Top